Quelling the data analysis bottleneck while leveraging 4D-Proteomics™ benefits

ZÁZNAM | Proběhlo St, 29.11.2023

Tento webinář předvede, jak platforma Bruker ProteoScape™ podporuje projekty 4D-Proteomics™, od vysokorychlostní identifikace a kvantifikace na základě dda a dia až po správu QC nebo podporu DeNovo.

Přejít na webinář

Bruker: Quelling the data analysis bottleneck while leveraging 4D-Proteomics™ benefits

The 4D-Proteomics™ approaches have reached a level of combined performance, robustness, and reproducibility compatible with large scale clinical research projects. If not taken care of, the data processing stage can be a bottleneck for the full process. In this webinar, Dr. Jonathan Krieger will demonstrate how the Bruker ProteoScape™ platform supports such projects, from high-speed dda and dia based identification and quantification to QC management or DeNovo support, and discuss the latest introduction that have been introduced to improve the large projects handling capabilities.

Presenter: Jonathan Krieger, Ph.D. (Head of Research, Bruker ProteoScape™, Bruker Daltonics, Canada)

Moderator: Pierre-Olivier Schmit (Market Manager Proteomics, Bruker Daltonics, France)

Bruker

Quelling the data analysis bottleneck while leveraging 4D-Proteomics™ benefits

Mohlo by Vás zajímat

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector